Evidence-based medicine is an important piece of the puzzle for improving patient care. We aim to be a world leader in developing scientific evidence to fill the gaps in knowledge related to women’s cardiovascular health. By incorporating sex and gender considerations in all research within the Libin Cardiovascular Institute, we hope to better understand the unique challenges women face at all stages of their lives.
It’s critical that physicians and researchers are aware that individuals have unique biological sex and gender differences and that each individual needs to receive the right treatment at the right time for them. Our aim is to increase awareness about the need to incorporate sex and gender considerations in research to optimize patient care.
We are taking a practical approach to improving women’s cardiovascular health in Calgary by developing a Calgary-based clinic. Health care providers at this clinic will follow the latest evidence-based medical guidelines in cardiovascular prevention, management and rehabilitation to provide patient-centred care. Besides providing top-notch care, the clinic will create an opportunity for researchers to connect with patients to better incorporate their experiences and voices into women’s cardiovascular health research.
We aim to help women better understand, and ultimately, take charge, of their own cardiovascular health. Women are empowered to improve their own cardiovascular health when they are aware of the unique challenges they may face. By connecting them with experts and supporting programs, we will improve their cardiovascular health outcomes.
The Equity, Diversity and Inclusion (EDI) Committee was created in early 2021 to ensure EDI best practices are incorporated into all aspects of the Libin Cardiovascular Institute. The guiding principle of the committee is to ensure that our members and the community we support can work, learn and heal in a physically and psychologically safe environment.
The goals of this committee are:
- To develop and assess EDI policies within the LCI context
- To implement and embed EDI best practices within the LCI.
- To advise LCI leadership when a breach of EDI or harassment policy occurs.
Dr. Michelle Keir created the committee to address areas of inequity within the Institute's clinical domain. In 2022, Dr. Keir was named the EDI Lead, and the Committee was expanded to cover the academic space to unify all EDI and harassment policies.
Dr. Lauren Drogos – Program Director
Dr. Drogos, PhD, coordinates the Libin Cardiovascular Institute’s Women’s Cardiovascular Health Initiative. Her education and research background are in women’s health, with a focus on mental health and cognition. She received her PhD from the University of Illinois at Chicago in Psychology, within the division of Behavioral Neuroscience. She has also completed postdoctoral training at the University of Calgary within the departments of Physiology and Pharmacology, and Psychology.
Dr. Roopinder K. Sandhu - Director
Roopinder K. Sandhu MD, MPH, FHRS, is a clinician-scientist and Professor of Cardiac Sciences at the University of Calgary. She is the Martha Brauer Chair in Women’s Cardiovascular Health Research and serves as the Director of the Women’s Cardiovascular Health Clinic (under-development) and Initiative. Dr. Sandhu’s research program focuses on epidemiology and health services research within the field of cardiac electrophysiology, with a particular focus on atrial fibrillation (AF), syncope, and sudden cardiac death (SCD). Dr. Sandhu has been on the writing panel or co-chaired several guideline documents and received grant support from the Heart & Stroke Foundation of Canada, Canadian Stroke Prevention Intervention Network, and National Institutes of Health Research. She currently serves as a member on the Heart Rhythm Society (HRS) Research Committee, HRS AF Quality Improvement Committee, HRS AF Centers of Excellence Working Group and Canadian Heart Rhythm Research Committee.